Adverse Cases
- Lenalidomide (Revlimid) and second primary malignancy
- Accidental paracetamol poisoning
- Strontium ranelate and venous thromboembolism and serious skin reactions
- Candesartan, fetal malformations and use in pregnancy
- Zolpidem: continued reporting of abnormal sleep-related events and amnesia
- Renal function assessment in prescribing
- Anaphylaxis with chlorhexidine-impregnated central venous catheters
- Change in the pregnancy category for topiramate
- Dasatinib (Sprycel) and pulmonary arterial hypertension
- Pulmonary oedema associated with topical phenylephrine
- Pneumovax 23 - updated revaccination recommendations
- Citalopram and QT prolongation - important changes to the dosing recommendations
- Atomoxetine (Strattera) - risk of increased blood pressure and/or heart rate
- Proton pump inhibitors and acute interstitial nephritis
- Dabigatran (Pradaxa) and the risk of bleeding
- Risk of myopathy and rhabdomyolysis with simvastatin – new dosage recommendations and contraindications
- Oral contraceptives containing drospirenone (Yaz and Yasmin) and venous thromboembolism
- Pioglitazone and risk of bladder cancer
- Modafinil (Modavigil) - safety update
- Cramps, quinine and thrombocytopenia
- Venlafaxine and stress cardiomyopathy
- In utero antipsychotic exposure and neonatal extrapyramidal and withdrawal adverse effects
- Prescribing medicines in pregnancy - new TGA database
- Risk of hypomagnesaemia with proton pump inhibitors
- Drug-induced hyponatraemia
- Rotavirus vaccination and risk of intussusception: investigation of a possible safety signal
- Coversyl and Coumadin: new packaging to reduce potential for dispensing errors
- Clozapine and severe constipation
- Drug interaction between tamoxifen and antidepressants
- Methysergide and retroperitoneal fibrosis